Thryvv : ratio page

Gland Pharma

Overview Articles News Financials Ratios Shareholding Peers

Financial Ratios

View
Order
Financial Ratios
Mar2024
Mar2023
Mar2022
Mar2021
Mar2020
Valuation Parameters:
PE(x)
39.27
26.75
44.33
40.66
0.00
PCE(x)
27.16
22.52
40.63
36.99
0.00
Price/Book(x)
3.48
2.63
7.52
6.90
0.00
EV/Net Sales(x)
5.09
4.73
11.50
10.84
-0.50
EV/Core EBITDA(x)
19.17
13.54
29.19
26.12
-1.19
EV/EBIT(x)
24.87
16.13
31.18
28.05
-1.30
EV/CE(x)
3.19
2.15
7.07
5.78
-0.36
MCap / Sales
5.36
5.76
12.21
11.71
0.00
Growth Ratio:
Net Sales Growth(%)
56.29
-17.64
27.08
31.51
0.00
Core EBITDA Growth(%)
18.82
-27.04
20.67
31.28
0.00
EBIT Growth(%)
9.11
-34.60
21.34
33.82
0.00
PAT Growth(%)
-1.10
-35.54
21.54
29.00
0.00
EPS Growth(%)
-1.10
-35.70
21.01
22.18
0.00
Financial Stability Ratios:
Total Debt/Equity(x)
0.04
0.00
0.00
0.00
0.00
Current Ratio(x)
4.04
9.46
10.05
10.00
7.93
Quick Ratio(x)
2.85
6.80
8.02
7.51
5.82
Interest Cover(x)
44.23
142.61
309.77
392.33
139.24
Operational & Financial Ratios:
Earnings Per Share (Rs)
46.90
47.42
73.75
60.94
49.88
CEPS(Rs)
67.82
56.33
80.46
66.98
55.98
DPS(Rs)
20.00
0.00
0.00
0.00
0.00
Book NAV/Share(Rs)
529.56
483.12
434.84
359.30
234.25
Tax Rate(%)
31.79
25.94
25.14
25.31
22.16
Margin Ratios:
Core EBITDA Margin(%)
23.53
28.27
34.32
37.61
36.28
EBIT Margin(%)
20.46
29.30
36.90
38.64
37.98
Pre Tax Margin(%)
19.99
29.10
36.78
38.55
37.71
PAT Margin (%)
13.64
21.55
27.53
28.79
29.35
Cash Profit Margin (%)
19.72
25.60
30.04
31.64
32.94
Performance Ratios:
ROA(%)
7.97
9.40
16.91
18.84
18.91
ROE(%)
9.26
10.34
18.61
20.97
21.29
ROCE(%)
13.63
14.04
24.85
28.00
27.39
Asset Turnover(x)
0.58
0.44
0.61
0.65
0.64
Sales/Fixed Asset(x)
1.55
1.66
2.51
2.49
1.95
Working Capital/Sales(x)
1.33
0.59
0.84
0.75
1.06
Efficiency Ratios:
Fixed Capital/Sales(x)
0.64
0.60
0.40
0.40
0.51
Receivable days
78.29
97.99
72.40
67.08
83.41
Inventory Days
116.00
157.65
102.05
107.06
104.83
Payable days
121.78
113.72
74.34
96.63
108.75